Pathstone Holdings LLC Buys 6,134 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Pathstone Holdings LLC grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 9.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,895 shares of the company’s stock after buying an additional 6,134 shares during the period. Pathstone Holdings LLC’s holdings in Option Care Health were worth $2,156,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of OPCH. UMB Bank n.a. raised its position in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the last quarter. GAMMA Investing LLC increased its position in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the last quarter. Blue Trust Inc. increased its position in Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the last quarter. Finally, International Assets Investment Management LLC increased its position in Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

OPCH has been the topic of several research reports. JMP Securities boosted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Truist Financial dropped their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, Barrington Research dropped their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and a consensus price target of $30.83.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Up 1.5 %

NASDAQ OPCH opened at $23.74 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a fifty day moving average of $27.30 and a two-hundred day moving average of $29.00. The firm has a market capitalization of $4.04 billion, a price-to-earnings ratio of 19.95, a PEG ratio of 2.39 and a beta of 1.32. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.